Compare Heartflow Inc. Common Stock (HTFL) vs Synopsys, Inc. (SNPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heartflow Inc. Common Stock vs Synopsys, Inc. — how do they compare? Heartflow Inc. Common Stock trades at $51.12 (market cap $4.30B), while Synopsys, Inc. trades at $465 (market cap $91.97B). The key difference: Synopsys, Inc. is far larger — about 21.4× Heartflow Inc. Common Stock's market cap, and Heartflow Inc. Common Stock is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and Synopsys, Inc. for 72 Days on average.
| HTFL | SNPS | |
|---|---|---|
Market Cap | $4.30B | $91.97B |
Volume | 1,616,039 | 3,203,530 |
Sector | Health | Technology |
52-Week High | $52.21 | $534.56 |
52-Week Low | $20.49 | $367.70 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $4.17B | $99.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Synopsys (SNPS) trades at $494.51, down 1.59% on the day, but maintains a bullish technical outlook with strong support near $493. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $3.91 exceeding expectations. Recent news highlights partnerships with OpenAI and Amazon, fueling investor optimism and driving a 13% stock surge on October 1, 2026. Valuation ratios remain elevated, with a P/E of 83.76, reflecting high growth expectations.
The outlook for SNPS is positive, supported by AI-driven demand and strategic acquisitions, but risks include high valuation and integration challenges from the Ansys deal. Analyst consensus is strongly bullish with a $575.93 price target, indicating ~16% upside. Investors should weigh growth potential against execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heartflow Inc. Common Stock
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →
